Global Radiopharmaceuticals Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Radiopharmaceuticals Market
The global Radiopharmaceuticals market size is projected to reach US$ 10730 million by 2027, from US$ 6260.1 million in 2020, at a CAGR of 8.0% during 2021-2027.
Global Radiopharmaceuticals Scope and Segment
The global Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

By the product type, the market is primarily split into
Diagnostic Radioisotopes
Therapeutic Radioisotopes
By the end users/application, this report covers the following segments
Oncology
Cardiology
Other

Competitive Landscape:

The report provides a list of all the key players in the Radiopharmaceuticals market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.

The Radiopharmaceuticals key manufacturers in this market include:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

TABLE OF CONTENT

1 Radiopharmaceuticals Market Overview
1.1 Radiopharmaceuticals Product Overview
1.2 Radiopharmaceuticals Market Segment by Type
1.2.1 Diagnostic Radioisotopes
1.2.2 Therapeutic Radioisotopes
1.3 Global Radiopharmaceuticals Market Size by Type
1.3.1 Global Radiopharmaceuticals Market Size Overview by Type (2016-2027)
1.3.2 Global Radiopharmaceuticals Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Radiopharmaceuticals Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Radiopharmaceuticals Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Radiopharmaceuticals Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Radiopharmaceuticals Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Radiopharmaceuticals Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Radiopharmaceuticals Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Radiopharmaceuticals Sales Breakdown by Type (2016-2030)
1.4.2 Europe Radiopharmaceuticals Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Radiopharmaceuticals Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Type (2016-2030)

2 Global Radiopharmaceuticals Market Competition by Company
2.1 Global Top Players by Radiopharmaceuticals Sales (2016-2030)
2.2 Global Top Players by Radiopharmaceuticals Revenue (2016-2030)
2.3 Global Top Players Radiopharmaceuticals Price (2016-2030)
2.4 Global Top Manufacturers Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type
2.5 Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceuticals Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2020)
2.7 Date of Key Manufacturers Enter into Radiopharmaceuticals Market
2.8 Key Manufacturers Radiopharmaceuticals Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Radiopharmaceuticals Status and Outlook by Region
3.1 Global Radiopharmaceuticals Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Radiopharmaceuticals Historic Market Size by Region
3.2.1 Global Radiopharmaceuticals Sales in Volume by Region (2016-2030)
3.2.2 Global Radiopharmaceuticals Sales in Value by Region (2016-2030)
3.2.3 Global Radiopharmaceuticals Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Radiopharmaceuticals Forecasted Market Size by Region
3.3.1 Global Radiopharmaceuticals Sales in Volume by Region (2022-2027)
3.3.2 Global Radiopharmaceuticals Sales in Value by Region (2022-2027)
3.3.3 Global Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Radiopharmaceuticals by Application
4.1 Radiopharmaceuticals Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceuticals Market Size by Application
4.2.1 Global Radiopharmaceuticals Market Size Overview by Application (2016-2027)
4.2.2 Global Radiopharmaceuticals Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Radiopharmaceuticals Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Radiopharmaceuticals Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Radiopharmaceuticals Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Radiopharmaceuticals Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Radiopharmaceuticals Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Radiopharmaceuticals Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Radiopharmaceuticals Sales Breakdown by Application (2016-2030)
4.3.2 Europe Radiopharmaceuticals Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Radiopharmaceuticals Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Application (2016-2030)

5 North America Radiopharmaceuticals by Country
5.1 North America Radiopharmaceuticals Historic Market Size by Country
5.1.1 North America Radiopharmaceuticals Sales in Volume by Country (2016-2030)
5.1.2 North America Radiopharmaceuticals Sales in Value by Country (2016-2030)
5.2 North America Radiopharmaceuticals Forecasted Market Size by Country
5.2.1 North America Radiopharmaceuticals Sales in Volume by Country (2022-2027)
5.2.2 North America Radiopharmaceuticals Sales in Value by Country (2022-2027)

6 Europe Radiopharmaceuticals by Country
6.1 Europe Radiopharmaceuticals Historic Market Size by Country
6.1.1 Europe Radiopharmaceuticals Sales in Volume by Country (2016-2030)
6.1.2 Europe Radiopharmaceuticals Sales in Value by Country (2016-2030)
6.2 Europe Radiopharmaceuticals Forecasted Market Size by Country
6.2.1 Europe Radiopharmaceuticals Sales in Volume by Country (2022-2027)
6.2.2 Europe Radiopharmaceuticals Sales in Value by Country (2022-2027)

7 Asia-Pacific Radiopharmaceuticals by Region
7.1 Asia-Pacific Radiopharmaceuticals Historic Market Size by Region
7.1.1 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Radiopharmaceuticals Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Radiopharmaceuticals Forecasted Market Size by Region
7.2.1 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Radiopharmaceuticals Sales in Value by Region (2022-2027)

8 Latin America Radiopharmaceuticals by Country
8.1 Latin America Radiopharmaceuticals Historic Market Size by Country
8.1.1 Latin America Radiopharmaceuticals Sales in Volume by Country (2016-2030)
8.1.2 Latin America Radiopharmaceuticals Sales in Value by Country (2016-2030)
8.2 Latin America Radiopharmaceuticals Forecasted Market Size by Country
8.2.1 Latin America Radiopharmaceuticals Sales in Volume by Country (2022-2027)
8.2.2 Latin America Radiopharmaceuticals Sales in Value by Country (2022-2027)

9 Middle East and Africa Radiopharmaceuticals by Country
9.1 Middle East and Africa Radiopharmaceuticals Historic Market Size by Country
9.1.1 Middle East and Africa Radiopharmaceuticals Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Radiopharmaceuticals Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Radiopharmaceuticals Forecasted Market Size by Country
9.2.1 Middle East and Africa Radiopharmaceuticals Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Radiopharmaceuticals Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Radiopharmaceuticals Business
10.1 Bracco Imaging
10.1.1 Bracco Imaging Corporation Information
10.1.2 Bracco Imaging Introduction and Business Overview
10.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Bracco Imaging Radiopharmaceuticals Products Offered
10.1.5 Bracco Imaging Recent Development
10.2 Bayer
10.2.1 Bayer Corporation Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Bayer Radiopharmaceuticals Products Offered
10.2.5 Bayer Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Corporation Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Mallinckrodt Radiopharmaceuticals Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Nordion
10.4.1 Nordion Corporation Information
10.4.2 Nordion Introduction and Business Overview
10.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Nordion Radiopharmaceuticals Products Offered
10.4.5 Nordion Recent Development
10.5 Triad Isotopes
10.5.1 Triad Isotopes Corporation Information
10.5.2 Triad Isotopes Introduction and Business Overview
10.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Triad Isotopes Radiopharmaceuticals Products Offered
10.5.5 Triad Isotopes Recent Development
10.6 Lantheus
10.6.1 Lantheus Corporation Information
10.6.2 Lantheus Introduction and Business Overview
10.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Lantheus Radiopharmaceuticals Products Offered
10.6.5 Lantheus Recent Development
10.7 IBA Group
10.7.1 IBA Group Corporation Information
10.7.2 IBA Group Introduction and Business Overview
10.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.7.4 IBA Group Radiopharmaceuticals Products Offered
10.7.5 IBA Group Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Corporation Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.8.4 GE Healthcare Radiopharmaceuticals Products Offered
10.8.5 GE Healthcare Recent Development
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Corporation Information
10.9.2 China Isotope & Radiation Introduction and Business Overview
10.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered
10.9.5 China Isotope & Radiation Recent Development
10.10 Jubilant Pharma
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Radiopharmaceuticals Product Category, Application and Specification
10.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Jubilant Pharma Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Corporation Information
10.11.2 Eli Lilly Introduction and Business Overview
10.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Eli Lilly Radiopharmaceuticals Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Advanced Accelerator Applications
10.12.1 Advanced Accelerator Applications Corporation Information
10.12.2 Advanced Accelerator Applications Introduction and Business Overview
10.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
10.12.5 Advanced Accelerator Applications Recent Development
10.13 SIEMENS
10.13.1 SIEMENS Corporation Information
10.13.2 SIEMENS Introduction and Business Overview
10.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.13.4 SIEMENS Radiopharmaceuticals Products Offered
10.13.5 SIEMENS Recent Development
10.14 Dongcheng
10.14.1 Dongcheng Corporation Information
10.14.2 Dongcheng Introduction and Business Overview
10.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.14.4 Dongcheng Radiopharmaceuticals Products Offered
10.14.5 Dongcheng Recent Development
10.15 Navidea
10.15.1 Navidea Corporation Information
10.15.2 Navidea Introduction and Business Overview
10.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2030)
10.15.4 Navidea Radiopharmaceuticals Products Offered
10.15.5 Navidea Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Radiopharmaceuticals Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Radiopharmaceuticals Industrial Chain Analysis
11.4 Radiopharmaceuticals Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Radiopharmaceuticals Distributors
12.3 Radiopharmaceuticals Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample